Dr. Denis Garceau

Global Project Leader, Kiacta

Dr. Garceau is Global Project Leader of Auven Therapeutics’ portfolio program, Kiacta, which was acquired from BELLUS Health. Dr. Garceau also directs BELLUS Health’s drug development program, from toxicology to clinical evaluation through to approval of new products, and has been with the Company since March 1997. As a clinical scientist and product team leader for Hoechst Marion Roussel (now Sanofi-Aventis), Dr. Garceau successfully oversaw North American clinical programs and participated in global clinical development steering committees. He was responsible for developing clinical operating plans, designing clinical protocols, and supervising clinical trials. Dr. Garceau holds a Ph.D. in Pharmacology from the Université de Montréal, and is currently a guest lecturer for the faculty of pharmacy of the Université de Montreal and Université Laval.